Triple negative breast cancer (TNBC) is a form of BRCA that is distinguished by the lack of estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER2) (Jiang et al. 2019; Chen et al. 2023). This evidence concerns the gene PGR and triple-negative breast carcinoma.